Throughout the last three months, 7 analysts have evaluated Silence Therapeutics (NASDAQ:SLN), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 3 | 1 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $65.57, a high estimate of $75.00, and a low estimate of $49.00. Surpassing the previous average price target of $63.14, the current average has increased by 3.85%.
Diving into Analyst Ratings: An In-Depth Exploration
The...
Login or create a forever free account to read this news
Sign up/Log in
